Skip to content
Microbot Medical logo

Microbot Medical

MBOT

Microbot Medical is a clinical-stage medical device company developing next-generation robotic platforms for minimally invasive endoluminal surgery.

Market cap
$124.93M+25.0%
Revenue$190.2K+62.4%
Net income-$14.2M-21.8%
Free cash flow-$15.4M-65.3%
EPS (diluted)-$0.26+60.0%
Trailing twelve months · change vs. prior year

Earnings

Next report

Aug 11, 2026 (in a month)
Revenue estimate$583.3K
EPS estimate-$0.09

Financials

Q1 2026

Income statement

See full
Revenue$105.0K
Gross profit$2.0K
Operating income-$4.3M-43.0%
Net income-$3.7M-41.1%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$3.7M+13.7%
Total debt$898.0K+551%
Total equity$74.1M+156%
Total assets$78.1M+153%

Cash flow

See full
Operating cash flow-$5.1M-75.8%
CapEx$108.0K+731%
Free cash flow-$5.2M-78.8%

Valuation & ratios

Valuation

See full
Market cap$124.93M+25.0%
Enterprise value$122.17M+34.2%
P/S656.7×

Returns & leverage

See full
Return on equity-27.6%-10.2pp
Debt / equity0.0×
Current ratio22.6×+6.4×

Competitors

Profile

Microbot Medical is a clinical-stage medical device company developing next-generation robotic platforms for minimally invasive endoluminal surgery. The company's core value proposition is the creation of compact, fully disposable robotic systems that improve surgical outcomes, reduce physician radiation exposure, and eliminate the need for expensive, dedicated capital equipment in catheterization labs.

Competitive position

Microbot is a pioneer in the fully disposable endovascular robotics niche, positioning itself as a lower-cost, mobile alternative to traditional heavy-capital robotic systems.

GeographiesUnited States, Israel, European Union
Customer segmentsHospitals, Specialized Medical Practitioners, Health Care Systems
Business modelMedical Device Manufacturing, Disposable Consumables, Research and Development
SuppliersThird-party contract manufacturers, Plastic injection mold designers, Academic research institutions, Specialized component suppliers
CustomersHospitals, Interventional radiology departments, Medical device distributors, Outpatient surgical centers
Listed1992
Employees22.0
CEOHarel Gadot
FilingsSEC EDGAR

Questions, answered.

What is Microbot Medical's market cap?
Microbot Medical (MBOT) has a market capitalization of $124.9M and trades on NASDAQ.
What is Microbot Medical's revenue and profitability?
Microbot Medical generated $190.2K in trailing twelve-month revenue with a net loss of $14.2M, representing a net margin of -3669.9%, with free cash flow of -$15.4M. These figures are based on the Q1 2026 filing.
Who are Microbot Medical's competitors?
Microbot Medical's key competitors include Medtronic, Intuitive Surgical, Integer Holdings Corporation, and others. These companies compete in similar markets and product categories.
Who does Microbot Medical partner with?
Microbot Medical's notable partners include Corewell Health, Emory University, The Technion Research and Development Foundation Ltd., and others.
What subsidiaries does Microbot Medical have?
Microbot Medical's subsidiaries include Microbot Medical Ltd..
Where is Microbot Medical headquartered?
Microbot Medical is headquartered in United States of America and employs approximately 22 people. It has been publicly traded since 1992.